Web Access Research Portal

Researcher: Lowenthal, RM (Professor Ray Lowenthal)

Fields of Research

Oncology and carcinogenesis
Haematology
Health services and systems
Medical genetics (excl. cancer genetics)
Cancer genetics
Clinical sciences
Rheumatology and arthritis
Cellular immunology
Health promotion
Cardiology (incl. cardiovascular diseases)
Cancer cell biology
Mental health nursing
Bioassays
Cancer diagnosis
Clinical chemistry (incl. diagnostics)
Clinical pharmacology and therapeutics
Acute care
Medical biochemistry - proteins and peptides (incl. medical proteomics)
Transplantation immunology
Neurology and neuromuscular diseases
Foetal development and medicine
Biochemistry and cell biology
Haematological tumours
Occupational and workplace health and safety
Anaesthesiology
Epidemiology
Medical biochemistry - lipids
Preventative health care
Chemotherapy
Cancer therapy (excl. chemotherapy and radiation therapy)
Genetics

Research Objectives

Clinical health
Other health
Diagnosis of human diseases and conditions
Health policy evaluation
Preventive medicine
Men's health
Measurement standards and calibration services
Nursing
Evaluation of health outcomes
Expanding knowledge in the biological sciences
Dental health
Women's and maternal health
Expanding knowledge in the environmental sciences

Career Best Publications

Research Publications

20-year remission of rheumatoid arthritis in two patients after allogeneic bone marrow transplantation; Journal of Rheumatology
A phase I/II study of intensive dose escalation of cytarabin in combinaton with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia; Leukemia and Lymphoma
A quantitative method to detect fucoidan in human plasma using a novel antibody; Methods and Findings in Experimental and Clinical Pharmacology
A quantitative method to detect fucoidan in human plasma using a novel antibody; 43rd Scientific Conference of Australasian Association of Clinical Biochemists
A randomized controlled clinical trial to determine the optimum duration of G-CSF priming prior to BM stem cell harvesting; Cytotherapy
A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC); ECCO 12 - the European Cancer Conference
A randomized study of high dose cytarabine in induction in acute myeloid leukemia; Blood
A randomized trial of high-dose versus conventional-dose cytarabine in consolidation chemotherapy for adult de nova acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine; Blood
A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study; Oncology Reports
Absence of simian virus 40 (SV40) DNA in lymphoma samples from Tasmania, Australia; Pathology
Address to AMA Tasmanian Branch Annual General Meeting 10 May by President, Professor Ray Lowenthal
Alan Coates and the Cancer Council Australia; Cancer Forum
Alternative cancer treatments; Medical Journal of Australia
An outpatient salvage approach for advanced lymphoma incorporating stratification and dose-escalation; 47th Annual Meeting of the American Society of Hematology
An unusual cause of lead poisoning.; Hematology Society of Australia Annual Scientific Meeting, October, 1994
Anticipation in familial hematologic malignancies; Blood
Are seaweed-derived fucoidans possible future anti-cancer agents?; Journal of Phycology
Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation; Bone Marrow Transplantation
Autologous Hemopoietic Stem Cell Transplantation in Severe Rheumatoid Arthritis: A Report from the EBMT and ABMTR; The Journal of Rheumatology
Autologous stem cell transplantation in rheumatoid arthritis; American Society of Hematology
Blood cell transplantation (BCT); 22nd Australian and New Zealand Scientific Meeting on Intensive Care
Bone marrow transplantation for patients with advanced breast cancer after >2 chemotherapy regimens; 26th Annual Scientific Meeting of the Clinical Oncological Society of Australia (COSA)
Can flow cytometric quantitation of CD34+ cells replace the colony assay as a predictor of engraftment in autologous bone marrow transplantation?; Hematology Society of Australia Annual Scientific Meeting, October, 1994
Cancer drugs system unfair: experts
Cancer impact on Indigenous communities: overview; Cancer Forum
Cancer impact on Indigenous communities: The Cancer Council Australia's Darwin conference - summary of presentations; Cancer Forum
Cancer quackery examined; The Skeptic
Carl De Gruchy Oration
Case report. Twenty-year remission of rheumatoid arthritis in 2 patients after allogenic bone marrow transplant; The Journal of Rheumatology
Cell Cycle Arrest of Hematopoietic Cell Lines After Treatment With Ceramide Is Commonly Associated With Retinoblastoma Activation; Cytometry
Chemotherapy at home; Palliative Care Today
Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship; Internal Medicine Journal
Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901; 2014 Genitourinary Cancers Symposium
Co-location: Threat or opportunity? The President's point of view
Cold sweat case report; The Lancet
Comparison of haematopoietic reconstitution after autologous transplantation using stem cells after short (<12 months) and long-term cryostorage; Haematology Society of Australia & New Zealand, Australian & New Zealand Society of Blood Transfusion, Australasian Society of Thrombosis & Haemostasis
Comparison of hematopoietic reconstruction after autologous transplantation using stem cells after short- (<12 months) and longer-term cryostorage; 47th Annual Meeting of the American Society of Hematology
Complementary and alternative medicine: The perspective of a medical oncologist; Perspectives on Complementary and Alternative Medicines
Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage; Cryobiology
Does hemopoietic stem cell transplantation have a role in treatment of severe rheumatoid arthritis?; Journal of Clinical Immunology
Does over a decade of remission from rheumatoid arthritis (RA) after bone marrow transplantation (BMT) represent a cure? Long term follow up of two Australian cases; Inaugural International Meeting of Haemopoietic Stem Cell Therapy in Autoimmune diseases, 26-28 Sept
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation; European Journal of Haematology
Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia; Leukemia
Effects of lenograstim (glycosylated huG-CSF) after high dose cytarabine-based induction chemotherapy for adult acute myeloid leukemia (AML); 41st Annual Meeting of the American Society of Hematology
Engraftment potential of Percoll-fractionated stem cell collections; VIII Congress Asian Pacific Division International Society of Haematology, October
Environmental exposure prior to development of myelodysplasa: a retrospective case-control study; 5th International Symposium on Myelodysplastic Syndromes
Euthanasia. What it really means and why the Medical profession opposes it
Evaluating a CLL susceptibility variant in ITGB2 in families with multiple sub-types of hematological malignancies; Blood
EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma; Annals of Oncology
EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901); 2014 Genitourinary Cancers Symposium
Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes ; British Journal of Haematology
Evolution of collaborative group AML studies in Australia; 2014 World Cancer Congress
Exposure to hydro-electric transmission power lines in patients with myeloproliferative and lymphoproliferative diseases (MPD & LPD): Preliminary analysis of a retrospective case-controlled study; COSA 25th Annual Scientific Meeting
Exposure to hydro-electric transmission power lines in patients with myeloproliferative and lymphoproliferative disorders: a retrospective case-controlled study.; VIII Congress Asian Pacific Division International Society of Haematology, October
Extracranial metastases of a glioblastoma multiforme to the pleura, small bowel and pancreas; Journal of Clinical Neuroscience
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience; Bone Marrow Transplantation
Familial Haematological Malignancies; GeneMappers
Familial Haematological malignancies: The Tasmanian experience; Haematology Society of Australia and New Zealand, Australia and New Zealand Society for Blood Transfusion & Australasian Society for Thrombosis and Homeostasis
Formation of an adherent hematopoietic expansion culture using fucoidan; Annals of Hematology
Fucoidan and cancer: a multifunctional molecule with anti-tumor potential; Marine Drugs
Fucoidan and CXCR4+ hemopoietic progenitor stem cell population; The Australian Health & Medical Research Congress
Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo; OncoTarget
Fucoidan ingestion increases the expression of CXCR4 on human CD34+ cells; Experimental Hematology
Fucoidan suppresses the growth of human acute promyelocytic leukemia cells in vitro and in vivo; Journal of Cellular Physiology
G-CSF primed bone marrow for autologous transplantation: rapid recovery of neutrophils and platelets comparable to that of peripheral blood stem cell transplantation; Conjoint Annual Scientific Meeting 35th Annual Scientific Meeting Scientific Meeting Haematology Society of Australia, 20th Annual Scientific Meeting New Zealand Society for Haematology, 31st Annual Scientific Meeting Au
G-CSF-primed bone marrow cells for autologous transplantation; Lancet
G-CSF-stimulated bone marrow (BM) harvests to obtain sufficient stem cells for autologous transplantation from extensively pre-treated patients.; American Society of Hematology 37th Annual Meeting, 1-5 December
G-CSF-stimulated bone marrow harvests in extensively pre-treated patients.; VIII Congress Asian Pacific Division International Society of Haematology, October
Glutathione S-transferase deletion polymorphism and myelodysplastic syndrome susceptibility; Medical Research Week
Haemopoietic stem cell transplantation (HSCT) for rheumatoid arthritis (RA); Annual Scientific Meeting of the Haematology Society of Australia, October, 1996
Haemopoietic stem cells remain viable after cryopreservation for up to 16 years; 38th Annual Meeting of the American Society of Hematology, 5-10 December, 1996
Hairy cell leukaemia 25 years on; The 1st Annual Scientific Meeting of the Haematology Society of Australia & New Zealand
Health Care Crisis now at breaking point
Health care crisis now at breaking point
Hemopoietic stem-cell harvesting and transplantation using G-CSF-primed BM: comparison with unprimed BM and G-CSF-primed PBSC; Cytotherapy
High dose consolidation chemotherapy with peripheral blood stem cell (PBSC) support for patients with limited stage small cell lung cancer (SCLC); Clinical Oncological Society of Australia COSA 2000 Scientific Meeting
High-dose melphalan and G- or GM-CSF for refractory multiple myeloma.; VIII Congress Asian Pacific Division International Society of Haematology, October
Home chemotherapy for cancer patients:cost analysis and safety; Medical Journal of Australia
Home chemotherapy in Tasmania - the problems and how to avoid them.; Australian Home and Outpatient Intravenous Therapy Association Scientific Meeting, 29 September.
Home treatment including chemotherapy for patients of a haematology/oncology unit: safe and cost-effective.; VIII Congress Asian Pacific Division International Society of Haematology, October
How low should taxes go?
Hypothesis. The importance of a histological diagnosis when diagnosing and treating advanced cancer. Famous patient recovery may not have been from metastatic disease; Internal Medicine Journal
Idarubicin dose escalation during consolidation therapy for adult acute myeloid leukemia; Journal of Clinical Oncology
Idarubicin, cytarabine in standard or high-dose, and etoposide lenograstim (G-CSF) for adult acute myeloid leukemia (AML). Combinations giving high remission rates.; American Society of Hematology 37th Annual Meeting, 1-5 December
Idarubicin, cytarabine in standard or high-dose, and etoposide lenograstim (G-CSF). Combinations giving high remission rates in acute myeloid leukaemia.; VIII Congress Asian Pacific Division International Society of Haematology, October
Identification of Susceptibility Genes for Haematological Maligancies; GeneMappers
Identification of the optimum length of G-CSF administration prior to bone marrow stem cell harvesting; Annual Scientific Meeting of Advancing Haematology Through Science
Identification of the optimum length of G-CSF administration prior to bone marrow stem cell harvesting; Annual Scientific Meeting of The Haematology Society of Australia & New Zealand
Improving survival in patients with Hodgkin's disease in Tasmania; COSA 24th Annual Scientific Meeting, 26-28 November 1997
Increased survival in patients diagnosed with Hodgkin's disease in Tasmania, 1972-1992; Australian and New Zealand Journal of Medicine
Induction of p121CIP1 expression and retinoblastoma activation by ceramide in leukaemia cells; 1999 ISAC Samuel A Latt Conference
Induction of p121CIP1 expression and retinoblastoma activation by ceramide in leukaemia cells; 1999 ISAC Samuel A Latt Conference
Innovative approaches to autologous bone marrow transplantation (BMT)- The Royal Hobart Hospital (RHH) experience; Haematology Society of Australia & New Zealand, Australian & New Zealand Society of Blood Transfusion, Australasian Society of Thrombosis & Haemostasis
Integrative Oncology in Australia; Journal of the Society for Integrative Oncology
Intensified induction chemotherapy with high dose Cytarabine and Etoposide for acute Myeloid Leukemia: A review and updated results of the Australian Leukemia study group; Leukemia and Lymphoma
Intensive chemotherapy in induction and consolidation for De Novo adult acute myeloid leukemia using sequential courses of high dose cytarabine, idarubicin, and etoposide: a randomized trial of the Australian leukaemia and lymphoma group (ALLG). ; American Society of Hematology
Interleukin-6: a prognostic factor in stem cell transplantation?; The 1st Annual Scientific Meeting of the Haematology Society of Australia & New Zealand
Is there life in the bottom of the freezer? - The effect of long term Cryostorage on haematopoietic stem cells; 8th Congress of the World Apheresis Association
Lead poisoning masquerading as chronic fatigue syndrome; Lancet
Letters; Medical Journal Of Australia
Linkage analysis of a large Tasmanian haematological cancer family; GeneMappers
Lymphoma studies by the Australasian Leukaemia and Lymphoma Group; Transfusion and Apheresis Science
Matters arising. Are ethics comittees retarding the development of health services in Australia; Medical Journal of Australia
Maximow PY, McDaniel RE, Jordan VC: Tamoxifen. Pioneering medicine in breast cancer
Mitochondrial cytochrome c release precedes transmembrane depolarisation and caspase-3 activation during ceramide-induced apoptosis of Jurkat T cells; Apoptosis
Mobilization of human hemopoietic progenitor stem cell via modulating CXCR4/SDF-1 using galactofucan sulfate; 47th Annual Meeting of the American Society of Hematology
Neutropenia alert cards; COSA 24th Annual Scientific Meeting, 26-28 November 1997
Neutropenia alert cards; Medical Journal Of Australia
One player too many in our health system?
Our Schizophrenic health system
Outpatient autologous bone marrow transplantation (BMT): a feasible and safe strategy; Clinical Oncological Society of Australia COSA 2000 Scientific Meeting
Outpatient autologous haemopoietic stem cell transplantation: a feasible and safe strategy; 18th UICC International Cancer Congress
Parathyroid hormone related protein (PTHrP) mediated hypercalcaemia complicating enteropancreatic malignancy in multiple endocrine neoplasia type 1 (MEN 1); Austrtalian & New Zealand Journal of Medicine
Pathologic Splenic Rupture as the Presentation of Mantle Cell Lymphoma; Leukemia and Lymphoma
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia; British Journal of Haematology
Pilot clinical study to evaluate the anticoagulant activity of fucoidan; Blood Coagulation & Fibrinolysis
President's Letter. Does the Medical School Deserve to be saved?
Presidential Musings
Presidential Musings
Presidents Report
Progress in blood stem cell transplantation for leukaemia; 37th National Scientific Conference
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation; Bone Marrow Transplantation
Public illness: how the community recommended complementary and alternative medicine for a prominent politician with cancer; Medical Journal of Australia
Recurrence of life-threatening DIC during all-trans retinoic acid (ATRA) therapy of acute promyelocytic leukemia (APML).; American Society of Hematology 37th Annual Meeting, 1-5 December
Reducing the impact of cancer in Indigenous communities: ways forward; Medical Journal of Australia
Reducing the toxicity of autologous stem cell transplants; Haematology Society of Australia & New Zealand, Australian & New Zealand Society of Blood Transfusion, Australasian Society of Thrombosis & Haemostasis
Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia; Leukemia
Reinfusion of bacterially contaminated blood stem cell autografts does not affect transplant mortality or engraftment; Haematology Society of Australia & New Zealand, Australian & New Zealand Society of Blood Transfusion, Australasian Society of Thrombosis & Haemostasis
Removal of DMSO prior to stem cell transplantation: Is this a feasible clinical practice?; Medical Research Week
Residential exposure to electric power transmission lines and risk of lymphoproliferative and myeloproliferative disorders: a case-control study; Internal Medicine Journal
Retrospecive review of the first 100 autologous haematopoietic stem cell transplants at the Royal Hobart Hospital; The 1st Annual Scientific Meeting of the Haematology Society of Australia & New Zealand
Retrospective analysis of outcome following autologous haematopoietic stem cell transplantation (HSCT) after long-term (>12) versus short-term (<12 months) cryopreservation; Bone Marrow Transplant Scientists' Association of Australasia
Retrospective analysis of outcome following autologous haematopoietic stem cell transplantation (HSCT) after long-term (>12) versus short-term (<12) months cryopreservation; The 1st Annual Scientific Meeting of the Haematology Society of Australia & New Zealand
Retrospective review of 100 consecutive allogeneic/autologous bone marrow (BM) and peripheral blood stem cell (PBSC) transplantations - a single institutions 19 years experience; COSA 25th Annual Scientific Meeting
Retrospective study of absence of expression of HLA-DR in acute myeloid leukaemia; Pathology Update 2013
Review article. Myelodysplastic syndromes
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab; Annals of Oncology
Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma; Journal of Clinical Oncology
Severe persistent sciatic pain and weakness due to a gluteal artery pseudoaneurysm as a complication of bone marrow biopsy; Journal of Clinical Neuroscience
Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis; European Journal of Cancer
Smoking gun
Tasmania 40° South
Telomere repeat lengths and telomere detection as predictors of transformation to acute myeloid leukemia in patients with MDS; 5th International Symposium on Myelodysplastic Syndromes
The effect of Undaria pinnatifida fucoidan on the pharmacokinetics of letrozole and tamoxifen in patients with breast cancer; Integrative Cancer Therapies
The effect of G-CSF on the composition of human bone marrow; 37th National Scientific Conference
The effect of G-CSF on the composition of human bone marrow; Clinical Laboratory Haematology
The effect of long-term cryostorage on hematopoietic stem cell viability and function; 7th Annual Symposium of the International Society for Hematotherapy and Graft Engineering (ISHAGE)
The end of the public hospital system as we know it?
The Familial Tasmanian Haematological Malignancies Study (FaTHMS): its origins, its history and the phenomenon of anticipation; Transfusion and Apheresis Science
The importance of inefficiency
The Prevalence of Complementary and Alternative Medicine Use Among Patients With Malignancy at Royal Hobart Hospital; Clinical Oncological Society of Australia, Annual Scientific Meeting
The risk of symptomatic venous thromboembolism in hospitalised patients with active cancer; National Medicines Symposium 2009
The Tasmanian familial leukaemia and lymphoma research study; Haematology Society of Australia and New Zealand, Australia and New Zealand Society for Blood Transfusion & Australasian Society for Thrombosis and Homeostasis
The Tasmanian familial leukaemia and lymphoma research study; GeneMappers
Toxicity of chemotherapy; Hematology - Oncology Clinics of North America
Use of 'rainy day' autologous haemopoietic stem cells: a single-institution experience over 10 years; Internal Medicine Journal
Validation of a stem cell washing procedure prior to autologous transplantation; The 1st Annual Scientific Meeting of the Haematology Society of Australia & New Zealand
Validation of a stem cell washing procedure prior to autologous transplantation; Bone Marrow Transplant Scientists' Association of Australasia
Viability of hematopoietic cells (HSCs) after long term cryostorage; 42nd Annual Meeting of the American Society of Hematology
Whole genome sequencing of CLL case; GeneMappers

Research Projects

A Pharmacokinetic Study of the Interaction Between Two Systemic Complementary and Alternative Medicines and Standard Therapy in Patients with Active Malignancy; Royal Hobart Hospital Research Foundation (RHHRF)
Analysis of Outpatient Bone Marrow Transplantation (BMT); David Collins Leukaemia Foundation (DCLF)
Blood Stem Cell Transplantation for Advanced Metastatic Breast Cancer; Cancer Council of Tasmania (CCT)
Data management in bone marrow transplantation; David Collins Leukaemia Foundation (DCLF)
Elevated Serum Interleukin-6 Levels: A Potential Prognostic Factor for Improved Bone Marrow Transplantation; David Collins Leukaemia Foundation (DCLF)
Elevated Serum Interleukin-6 Levels: A Potential Prognostic Factor for Improved Bone Marrow Transplantation; Clifford Craig Foundation (CCFoundation)
Environmental and occupational exposures of patients with myelodysplastic syndrome; Tasmanian Cancer Council (TCC)
Familial Haematological Malignancies: understanding the role of inherited causative factors; Cancer Council of Tasmania (CCT)
Genetic aetiology of familial haematological malignancies; Cancer Council of Tasmania (CCT)
Identification of Optimum Length of G-CSF Administration Prior to Bone Marrow Stem Cell Harvesting; Cancer Council of Tasmania (CCT)
Identification of susceptibility genes for familial haematological malignancies; Leukaemia Foundation (LF)
Identification of susceptibility genes for haematological malignancies; David Collins Leukaemia Foundation (DCLF)
Identifying inherited factors underlying familial haematological malignancies; David Collins Leukaemia Foundation (DCLF)
Improving the Outcome of Bone Marrow Transplantation; David Collins Leukaemia Foundation (DCLF)
Investigating the genetics of familial haematological cancers in Tasmania; David Collins Leukaemia Foundation (DCLF)
Investigating the genetics of familial haematological cancers in Tasmania; David Collins Leukaemia Foundation (DCLF)
Investigating the genetics of familial haematological cancers in Tasmania; Cancer Council of Tasmania (CCT)
Long Term Storage of Blood Stem Cells for Transplantation Clinical Results and Patient Outcomes; Cancer Council of Tasmania (CCT)
Methods to Enhance the Value of Haemopoietec Stem Cell Transplantation; Cancer Council of Tasmania (CCT)
Myelodysplastic syndrome; Tasmanian Cancer Council (TCC)
Occupational and environmental exposures of patients with myelodysplasia ...; Tasmanian Cancer Council (TCC)
Occupational and environmental exposures of patients with myelodysplasia ...; Tasmanian Cancer Council (TCC)
Optimising Administration of G-CSF Before and After Autologous Bone Marrow Transplantation; Cancer Council of Tasmania (CCT)
Removal of DMSO prior to stem cell transplantation: Is this a feasible clinical practice?; David Collins Leukaemia Foundation (DCLF)
Tasmanian familial haematological malignancy research study; Pfizer (PFIZER)
The ACRF Tasmanian Inherited Cancer Centre (ATICC); Australian Cancer Research Foundation (ACRF)
The Molecular Basis of Ceramide-Mediated Growth Arrest and Terminal Differentiation; David Collins Leukaemia Foundation (DCLF)
The Molecular Basis of Ceramide-Mediated Growth Arrest and Terminal Differentiation; Cancer Council of Tasmania (CCT)
Towards a Novel Differentiation Therapy of Leukaemia using Ceramide; David Collins Leukaemia Foundation (DCLF)
Towards a Novel Differentiation Therapy of Leukemia Using Ceramide; Cancer Council of Tasmania (CCT)
Validation of newly identified genes in the pathogenesis of chronic lymphocytic leukaemia; David Collins Leukaemia Foundation (DCLF)
Donation for Leukaemia Research by Professor R Lowenthal

Research Candidate Supervision

Clinical Haemopoietic Implications of Fucoidan Treatment
Genetic changes in myelodysplastic disorder (pre-Leukaemia) in Tasmania
Investigating the Genetic Predisposition for Familial Haematological Malignancies
Study of the Role of Fucoidan on Leukemia Cells and on Hematopoietic Stem Cell Release